Dr. Epstein attended the recent ASCRS meeting in New Orleans. Among his responsibilities, he had the honor to introduce his mentor., R. Doyle Stulting, MD, PhD, at a reception held in his honor, in commemoration of his delivery of the “Binkhorst lecture”. This lecture covered recent advances in the diagnosis and treatment of corneal ectasia and keratoconus, especially corneal crosslinking (CXL). CXL has recently been approved by the FDA. Dr. Stulting highlighted some of the studies done in this area by Chicago Cornea Consultants™.
